Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
Kim J, Kwon J, Lee D, Jo S, Park DS, Choi J, Park E, Hwang JY, Ko Y, Choi I, Ju MK, Ahn J, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Ahn S, Sommer P, Liuzzi M, No Z, Lee J. Kim J, et al. Among authors: ahn j, ahn s. Bioorg Med Chem Lett. 2013 Jan 1;23(1):153-7. doi: 10.1016/j.bmcl.2012.10.134. Epub 2012 Nov 12. Bioorg Med Chem Lett. 2013. PMID: 23206860
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors.
Kim J, Kwon J, Lee D, Jo S, Park DS, Choi J, Park E, Hwang JY, Ko Y, Choi I, Ju MK, Ahn J, Kim J, Han SJ, Kim TH, Cechetto J, Nam J, Ahn S, Sommer P, Liuzzi M, Lee J. Kim J, et al. Among authors: ahn j, ahn s. Bioorg Med Chem Lett. 2014 Dec 1;24(23):5473-7. doi: 10.1016/j.bmcl.2014.10.007. Epub 2014 Oct 23. Bioorg Med Chem Lett. 2014. PMID: 25455487
Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial.
Kim J, Choi J, Kang H, Ahn J, Hutchings J, Niekerk CV, Kim J, Jeon Y, Nam K, Kim TH, Shin BS, Shin S. Kim J, et al. Among authors: ahn j. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0112322. doi: 10.1128/aac.01123-22. Epub 2022 Dec 12. Antimicrob Agents Chemother. 2023. PMID: 36507677 Free PMC article. Clinical Trial.
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection.
Lee KY, Song KH, Lee KH, Baek JY, Kim ES, Song YG, Kim YC, Park YS, Ahn JY, Choi JY, Choi WS, Bae S, Kim SW, Kwon KT, Kang ES, Peck KR, Kim SH, Jeong HW, Ko JH. Lee KY, et al. Among authors: ahn jy. Vaccine. 2024 May 9:S0264-410X(24)00539-5. doi: 10.1016/j.vaccine.2024.05.003. Online ahead of print. Vaccine. 2024. PMID: 38729909
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
Kim SY, Kim JH, Kim TY, Park SR, Yoon S, Lee S, Lee SH, Kim TM, Han SW, Kim HR, Yun H, Lee S, Kim J, Choi YL, Choi KS, Chae H, Ryu H, Lee GW, Zang DY, Ahn JB. Kim SY, et al. Among authors: ahn jb. BMC Cancer. 2024 May 9;24(1):574. doi: 10.1186/s12885-024-12338-y. BMC Cancer. 2024. PMID: 38724991
10,657 results
You have reached the last available page of results. Please see the User Guide for more information.